Market revenue in 2023 | USD 173.6 million |
Market revenue in 2030 | USD 525.5 million |
Growth rate | 17.1% (CAGR from 2023 to 2030) |
Largest segment | Instruments |
Fastest growing segment | Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Consumables, Instruments, Services |
Key market players worldwide | Thermo Fisher Scientific Inc, Agilent Technologies Inc, Illumina Inc, Qiagen NV, Roche Holding AG, Macrogenics Inc, PerkinElmer, Pacific Biosciences of California Inc, BGI Group, BGC Group Inc Ordinary Shares Class A, Bio-Rad Laboratories Inc, Myriad Genetics Inc, PierianDx, Eurofins Scientific SE |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dna sequencing market will help companies and investors design strategic landscapes.
Instruments was the largest segment with a revenue share of 49.14% in 2023. Horizon Databook has segmented the Mexico dna sequencing market based on consumables, instruments, services covering the revenue growth of each sub-segment from 2018 to 2030.
High incidence of chronic & infectious diseases and growing medical tourism in the country, due to its cost-effective healthcare services, are significantly boosting the demand for NGS products for clinical applications. Furthermore, Mexico is the second-largest pharmaceutical market in Latin America after Brazil.
It has emerged as one of the potential countries for biopharmaceutical products, owing to the presence of skilled scientists, low manufacturing costs, and advanced legal framework. Moreover, high penetration of U.S.-based biotechnology companies in Mexico has supported the country’s biotechnology sector.
In addition, the Mexican government has prioritized growth and innovation in the biotechnology sector. Thus, growth in Mexico’s biopharmaceutical and biotechnology industries is anticipated to create high demand for NGS products in the region and support market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico dna sequencing market , including forecasts for subscribers. This country databook contains high-level insights into Mexico dna sequencing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account